Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A R Crossman

Showing results (21-30 of 91) with videos related to

Pageof 10
Sort By:
Experimental Neurology|December 17, 1997
The cannabinoid receptor agonist WIN 55,212-2 reduces D2, but not D1, dopamine receptor-mediated alleviation of akinesia in the reserpine-treated rat model of Parkinson's diseaseY P Maneuf, A R Crossman, J M Brotchie
Brain Research|April 23, 1990
Autoradiographic studies in animal models of hemi-parkinsonism reveal dopamine D2 but not D1 receptor supersensitivity. I. 6-OHDA lesions of ascending mesencephalic dopaminergic pathways in the ratW C Graham, A R Crossman, G N Woodruff
British Journal of Pharmacology|December 1, 1973
Picrotoxin antagonism of gamma-aminobutyric acid inhibitory responses and synaptic inhibition in the rat substantia nigraA R Crossman, R J Walker, G N Woodruff
Brain : a Journal of Neurology|June 1, 1985
Subcortical changes in the regional uptake of [3H]-2-deoxyglucose in the brain of the monkey during experimental choreiform dyskinesia elicited by injection of a gamma-aminobutyric acid antagonist into the subthalamic nucleusI J Mitchell, M A Sambrook, A R Crossman
Neuroscience Letters|March 14, 1994
A detailed anatomical analysis of neurotransmitter receptors in the putamen and caudate in Parkinson's disease and Alzheimer's diseaseP D Griffiths, R H Perry, A R Crossman
Neuroscience|July 1, 1993
Thalamotomy for the alleviation of levodopa-induced dyskinesia: experimental studies in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated parkinsonian monkeyR D Page, M A Sambrook, A R Crossman
Brain Research|February 5, 1993
Differential effect of chronic dopaminergic treatment on dopamine D1 and D2 receptors in the monkey brain in MPTP-induced parkinsonismW C Graham, M A Sambrook, A R Crossman
Brain Research|October 3, 1994
Neurons projecting from the entopeduncular nucleus to the thalamus receive convergent synaptic inputs from the subthalamic nucleus and the neostriatum in the ratM D Bevan, A R Crossman, J P Bolam
Neuropharmacology|June 1, 1985
Regional brain uptake of 2-deoxyglucose in N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism in the macaque monkeyA R Crossman, I J Mitchell, M A Sambrook
Journal of Anatomy|December 1, 1985
The organisation of the efferent projections of the zona incertaC A Romanowski, I J Mitchell, A R Crossman
Pageof 10

Showing results (21-30 of 91) with videos related to

Sort By:
Pageof 10
Experimental Neurology|December 17, 1997
The cannabinoid receptor agonist WIN 55,212-2 reduces D2, but not D1, dopamine receptor-mediated alleviation of akinesia in the reserpine-treated rat model of Parkinson's diseaseY P Maneuf, A R Crossman, J M Brotchie
Brain Research|April 23, 1990
Autoradiographic studies in animal models of hemi-parkinsonism reveal dopamine D2 but not D1 receptor supersensitivity. I. 6-OHDA lesions of ascending mesencephalic dopaminergic pathways in the ratW C Graham, A R Crossman, G N Woodruff
British Journal of Pharmacology|December 1, 1973
Picrotoxin antagonism of gamma-aminobutyric acid inhibitory responses and synaptic inhibition in the rat substantia nigraA R Crossman, R J Walker, G N Woodruff
Brain : a Journal of Neurology|June 1, 1985
Subcortical changes in the regional uptake of [3H]-2-deoxyglucose in the brain of the monkey during experimental choreiform dyskinesia elicited by injection of a gamma-aminobutyric acid antagonist into the subthalamic nucleusI J Mitchell, M A Sambrook, A R Crossman
Neuroscience Letters|March 14, 1994
A detailed anatomical analysis of neurotransmitter receptors in the putamen and caudate in Parkinson's disease and Alzheimer's diseaseP D Griffiths, R H Perry, A R Crossman
Neuroscience|July 1, 1993
Thalamotomy for the alleviation of levodopa-induced dyskinesia: experimental studies in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated parkinsonian monkeyR D Page, M A Sambrook, A R Crossman
Brain Research|February 5, 1993
Differential effect of chronic dopaminergic treatment on dopamine D1 and D2 receptors in the monkey brain in MPTP-induced parkinsonismW C Graham, M A Sambrook, A R Crossman
Brain Research|October 3, 1994
Neurons projecting from the entopeduncular nucleus to the thalamus receive convergent synaptic inputs from the subthalamic nucleus and the neostriatum in the ratM D Bevan, A R Crossman, J P Bolam
Neuropharmacology|June 1, 1985
Regional brain uptake of 2-deoxyglucose in N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism in the macaque monkeyA R Crossman, I J Mitchell, M A Sambrook
Journal of Anatomy|December 1, 1985
The organisation of the efferent projections of the zona incertaC A Romanowski, I J Mitchell, A R Crossman
Pageof 10